Doxorubicin resistance induces IL6 activation in the colon cancer cell line LS180

Despite improvements in the development of drugs for the treatment of cancer, drug resistance remains a major obstacle. In colon cancer, following an initially promising response, patients develop drug resistance, which impacts the efficacy and halts the response of cancerous cells towards drugs. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Yun, Liao, Xiao-Feng, Wang, Hong-Bo, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176352/
https://www.ncbi.nlm.nih.gov/pubmed/30344742
http://dx.doi.org/10.3892/ol.2018.9360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176352/
https://www.ncbi.nlm.nih.gov/pubmed/30344742
http://dx.doi.org/10.3892/ol.2018.9360

Ejemplares similares